• Medical Oncologists
• Radiation Oncologists
• Surgeons (oncology, colorectal, general, hepatobiliary)
• Gastroenterologists
• Radiologists
• Pathologists
• Genetic Counselors
• Physicians
• Allied Health Professionals
• Residents
• Fellows
• Nurses
• Medical Students

Professional Practice Gap 

Colorectal cancer remains among the most commonly diagnosed cancers and is responsible for a high proportion of cancer-related deaths in the United States. Over the last decade, there have been significant updates in the treatment of these patients. With the advent of total neoadjuvant therapy for rectal cancer, it is essential for clinicians to recognize nuances that influence the sequencing of chemotherapy and chemoradiation for these patients. In addition, understanding the evaluation and surveillance for rectal cancer patients who may be candidates for a “watch and wait” approach is important. Also, it is important that clinicians appreciate the evolving role of ctDNA in surveillance and treatment of colorectal cancer patients. Moreover, it is essential to appreciate how microsatellite status and mutational profiling inform appropriate utilization of immunotherapy and targeted therapies in colorectal cancer. Finally, having an appreciation for the role of metastasectomy for patients with stage IV disease and how surgery can improve survival in appropriately selected patients is critical to optimizing outcomes. This symposium is designed to give providers of all levels a contemporary perspective on the multidisciplinary management of colorectal cancer patients.